- Home
- LUCY vs NXPL Comparison
LUCY vs NXPL Comparison
Compare LUCY & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCY
- NXPL
- Stock Information
- Founded
- LUCY 2017
- NXPL 1997
- Country
- LUCY United States
- NXPL United States
- Employees
- LUCY N/A
- NXPL N/A
- Industry
- LUCY Ophthalmic Goods
- NXPL Telecommunications Equipment
- Sector
- LUCY Health Care
- NXPL Telecommunications
- Exchange
- LUCY Nasdaq
- NXPL Nasdaq
- Market Cap
- LUCY 18.5M
- NXPL 19.5M
- IPO Year
- LUCY 2022
- NXPL N/A
- Fundamental
- Price
- LUCY $5.55
- NXPL $1.28
- Analyst Decision
- LUCY Strong Buy
- NXPL
- Analyst Count
- LUCY 1
- NXPL 0
- Target Price
- LUCY $20.00
- NXPL N/A
- AVG Volume (30 Days)
- LUCY 53.0K
- NXPL 261.3K
- Earning Date
- LUCY 11-12-2024
- NXPL 11-14-2024
- Dividend Yield
- LUCY N/A
- NXPL N/A
- EPS Growth
- LUCY N/A
- NXPL N/A
- EPS
- LUCY N/A
- NXPL N/A
- Revenue
- LUCY $1,561,506.00
- NXPL $66,482,000.00
- Revenue This Year
- LUCY $68.16
- NXPL N/A
- Revenue Next Year
- LUCY $636.84
- NXPL N/A
- P/E Ratio
- LUCY N/A
- NXPL N/A
- Revenue Growth
- LUCY 158.62
- NXPL 179.89
- 52 Week Low
- LUCY $3.26
- NXPL $0.71
- 52 Week High
- LUCY $27.20
- NXPL $2.68
- Technical
- Relative Strength Index (RSI)
- LUCY 37.26
- NXPL 62.10
- Support Level
- LUCY $5.74
- NXPL $0.86
- Resistance Level
- LUCY $6.61
- NXPL $1.31
- Average True Range (ATR)
- LUCY 0.51
- NXPL 0.18
- MACD
- LUCY -0.07
- NXPL 0.05
- Stochastic Oscillator
- LUCY 0.00
- NXPL 79.17
About LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products Lucyd Lyte glasses enable the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone tasks hands free.
About NXPL NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.